Vickie & Jack Farber
Vision Research Center at Wills Eye
Advancing Science • Fostering Collaboration • Inspiring Innovation
Shortcodes Ultimate
Current IRIS® Registry Studies
The Wills Eye IRIS® Analytics Team has been intensely focused on multiples studies that use the IRIS Registry data to study the prevalence and risk factors for rare eye conditions, treatment outcomes using real world clinical data and disparities in eye care patterns. A few of the many ongoing studies are highlighted below.
Prevalence and Associated Factors for Thyroid Eye Disease
Thyroid Eye Disease (TED) is a rare, potentially debilitating and disfiguring eye condition. The prevalence of TED and its associated factors in the IRIS Registry are being examined in this large patient population.
Demographic disparities in Anti-Vascular Endothelial Growth Factor Therapy (VEGF) for Retinal Vein Occlusion (RVO)
Retinal Vein Occlusion (RVO) is one of the most common causes of retinal vascular diseases and risk factors include high blood pressure, vascular diseases and diabetes. The aim of this study is to investigate possible disparities between demographic groups in initiation of treatment with anti-VEGF injections and clinical outcomes for patients with RVO in the IRIS Registry.
Retinal Complications from Cataract Surgery
Cataract surgery is one of the most commonly performed surgical procedures in the United States and while cataract surgery is safe and effective in improving vision and visual functioning, post-surgical complications may occur. This study is using the data in the IRIS Registry to estimate the frequency of retinal complications within one year post cataract surgery, evaluate demographic and ocular risk factors for retinal events post cataract surgery, and compare differences in rates of retinal events among uncomplicated and complicated cataract procedures.